IP Library Granted Patent US 6,976,492
Granted Patent B2
US 6,976,492 · App. 10/338,193 · Granted Dec 20, 2005

Noninvasive devices, methods, and systems for shrinking of tissues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,976,492
App. No.
10/338,193
Granted
Dec 20, 2005
Kind
B2
Abstract

The invention provides improved devices, methods, and systems for shrinking of collagenated tissues, particularly for treating urinary incontinence in a noninvasive manner by directing energy to a patient's own support tissues. This energy heats fascia and other collagenated support tissues, causing them to contract. The energy can be applied intermittently, often between a pair of large plate electrodes having cooled flat electrode surfaces, the electrodes optionally being supported by a clamp structure. Such cooled plate electrodes are capable of directing electrical energy through an intermediate tissue and into fascia while the cooled electrode surface prevents injury to the intermediate tissue, particularly where the electrode surfaces are cooled before, during, and after an intermittent heating cycle. Ideally, the plate electrode comprises an electrode array including discrete electrode surface segments so that the current flux can be varied to selectively target the fascia. Alternatively, chilled “liquid electrodes” may direct current through a selected portion of the bladder (or other body cavity) while also cooling the bladder wall, an insulating gas can prevent heating of an alternative bladder portion and the adjacent tissues, and/or ultrasound transducers direct energy through an intermediate tissue and into fascia with little or no injury to the intermediate tissue. Cooled electrodes may be used to chill an intermediate engaged tissue so as to cause the maximum temperature difference between the target tissue and the intermediate tissue prior to initiating RF heating. This allows the dimensions of tissue reaching the treatment temperature to be controlled and/or minimized, the dimensions of protected intermediate tissue to be maximized, and the like.

Claims (28)

1. A method for treating urinary incontinence in a patient, the method comprising:

transmitting energy from a probe to a collagenous target tissue comprising or supporting the urethra of a patient, wherein the energy heats the target tissue so as to inhibit incontinence; and

cooling tissue in the vicinity of the probe.

2. The method of claim 1 , wherein transmitting energy is carried out by energizing an electrode of the probe.

3. The method of claim 2 , wherein the electrode comprises a needleless electrode.

4. The method of claim 2 , further comprising advancing the electrode of the probe into tissue, the electrode comprising a needle electrode.

5. The method of claim 1 , wherein the energy comprises RF energy.

6. The method of claim 1 , wherein cooling is carried out before, after, or during heating of the target tissue by the probe.

7. The method of claim 1 , wherein cooling is carried out by a cooled probe surface.

8. The method of claim 1 , wherein cooling is carried out by a cooled electrode.

9. The method of claim 1 , wherein cooling is carried out by delivering cooling fluids.

10. The method of claim 9 , wherein the fluid comprises chilled saline or water.

11. The method of claim 1 , wherein transmitting energy comprises repositioning a bladder or a bladder neck as a therapy for urinary incontinence.

12. The method of claim 1 , further comprising introducing the probe transvaginally.

13. A method for treating urinary incontinence in a patient, the method comprising:

directing energy from a probe, through an intermediate tissue, and into a target tissue, wherein the energy heats the target tissue so as to inhibit incontinence; and

cooling the intermediate tissue with the probe.

14. The method of claim 13 , wherein directing energy is carried out by energizing an electrode of the probe.

15. The method of claim 14 , wherein the electrode comprises a needleless electrode.

16. The method of claim 14 , further comprising advancing the electrode of the probe into tissue, the electrode comprising a needle electrode.

17. The method of claim 13 , wherein the energy comprises RF energy.

18. The method of claim 13 , wherein cooling is carried out before, after, or during heating of the target tissue by the probe.

19. The method of claim 13 , wherein cooling is carried out by a cooled probe surface.

20. The method of claim 13 , wherein cooling is carried out by a cooled electrode.

21. The method of claim 13 , wherein cooling is carried out by delivering cooling fluids.

22. The method of claim 21 , wherein the fluid comprises chilled saline or water.

23. The method of claim 13 , wherein directing energy comprises repositioning a bladder or a bladder neck as a therapy for urinary incontinence.

24. The method of claim 13 , further comprising introducing the probe transvaginally, the target tissue comprising endopelvic fascia and the intermediate tissue comprising a vaginal wall.

Assignments (8)
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
CORRECTED COVER SHEET TO CORRECT CONVEYANCE TYPE FROM NAME CHANGE TO ASSIGNMENT IN REEL/FRAME 030210/0343 Recorded Apr 18, 2013
From: AMS RESEARCH CORPORATION
To: VERATHON, INC.
Reel/Frame 030239/0284 →
CHANGE OF NAME Recorded Apr 12, 2013
From: AMS RESEARCH CORPORATION
To: VERATHON, INC.
Reel/Frame 030210/0343 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2011
From: CIT HEALTHCARE LLC
To: SOLARANT MEDICAL, INC.
Reel/Frame 026142/0160 →
SECURITY AGREEMENT Recorded Aug 17, 2006
From: SOLARANT MEDICAL, INC.
To: CIT HEALTHCARE LLC
Reel/Frame 018120/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2006
From: SOLARANT MEDICAL, INC.
To: AMS RESEARCH CORPORATION
Reel/Frame 018087/0904 →
CHANGE OF NAME Recorded Apr 14, 2004
From: SURX, INC.
To: SOLARANT MEDICAL, INC.
Reel/Frame 014523/0207 →